We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FSV:TSXFirstService Corp Analysis

Data as of 2026-06-01 - not real-time

CA$184.82

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

FirstService (FSV) is trading at C$184.8, just above its 20‑day SMA of C$180.9 but still below the 50‑day and 200‑day averages, indicating a short‑term bounce within a longer‑term downtrend. The RSI of 48.7 sits near the neutral zone, while the MACD histogram is positive and the MACD signal is flagged bullish, suggesting modest upside momentum despite the bearish trend direction. Volume has been increasing, supporting the technical bounce. However, the 30‑day volatility of nearly 37% and a max drawdown of over 40% highlight a high‑risk price environment. Valuation metrics are stretched: a trailing P/E of 37.6 exceeds the industry average of 32.3 and the DCF‑derived fair value of roughly C$99, placing the stock in the overvalued category. The forward P/E of 19.8 and projected EPS growth to C$9.32 signal improving earnings, aligning with the analyst’s “buy” rating and a median price target of C$246, implying ~33% upside from current levels.
Fundamentals show modest revenue growth of 5.3% and thin profit margins, but free cash flow remains healthy at C$345 M and the dividend payout ratio is a conservative 32%, supporting dividend sustainability. The recent tuck‑under acquisitions expand the Brands segment and could boost future cash generation. Debt levels are elevated (debt‑to‑equity ~72%) yet the company’s operating cash flow comfortably covers interest obligations. The market sentiment is extremely bullish (fear‑greed index 92.9) and the upcoming quarterly dividend of US$0.305 per share adds short‑term appeal. Given the mixed technical picture, overvalued pricing, and sector cyclicality, investors should weigh short‑term price risk against medium‑term earnings upside. A prudent approach is to monitor the support at C$169.6 and the resistance near C$192 while positioning for potential upside if earnings momentum sustains.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical bearish trend despite MACD bullish signal
  • Upcoming dividend provides modest yield
  • Valuation above fair value suggests limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Projected EPS growth and forward P/E compression
  • Acquisition‑driven revenue expansion
  • Analyst price target implying ~33% upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained free cash flow supports dividend
  • Elevated debt-to-equity ratio moderates upside
  • Valuation gap vs DCF suggests caution

Key Metrics & Analysis

Financial Health

Revenue Growth5.30%
Profit Margin2.92%
P/E Ratio37.6
ROE11.23%
ROA5.08%
Debt/Equity71.66
P/B Ratio4.3
Op. Cash FlowCA$492.9M
Free Cash FlowCA$345.6M
Industry P/E32.3

Technical Analysis

TrendBearish
RSI48.7
SupportCA$169.60
ResistanceCA$191.93
MA 20CA$180.94
MA 50CA$190.21
MA 200CA$222.09
MACDBullish
VolumeIncreasing
Fear & Greed Index92.98

Valuation

Fair ValueCA$99.32
Target PriceCA$246.41
Upside/Downside33.32%
GradeOvervalued
TypeBlend
Dividend Yield0.90%

Risk Assessment

Beta0.62
Volatility36.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.